Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$121.49B
Total volume
BTC 49.84%     ETH 15.35%
Dominance

iTeos Therapeutics ITOS Stock

13.53 USD {{ price }} 2.695517% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
484.78M USD
LOW - HIGH [24H]
12.83 - 13.7 USD
VOLUME [24H]
254.03K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-3.15 USD

iTeos Therapeutics Price Chart

iTeos Therapeutics ITOS Financial and Trading Overview

iTeos Therapeutics stock price 13.53 USD
Previous Close 13.99 USD
Open 13.99 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 13.58 - 14.23 USD
52 Week Range 12.52 - 28.05 USD
Volume 327.65K USD
Avg. Volume 273.47K USD
Market Cap 507.84M USD
Beta (5Y Monthly) 1.31991
PE Ratio (TTM) 48.96552
EPS (TTM) -3.15 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 42.25 USD

ITOS Valuation Measures

Enterprise Value -97177248 USD
Trailing P/E 48.96552
Forward P/E -2.6741996
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.9767628
Price/Book (mrq) 0.7785088
Enterprise Value/Revenue -0.761
Enterprise Value/EBITDA 5.614

Trading Information

iTeos Therapeutics Stock Price History

Beta (5Y Monthly) 1.31991
52-Week Change -23.69%
S&P500 52-Week Change 20.43%
52 Week High 28.05 USD
52 Week Low 12.52 USD
50-Day Moving Average 14.43 USD
200-Day Moving Average 17.81 USD

ITOS Share Statistics

Avg. Volume (3 month) 273.47K USD
Avg. Daily Volume (10-Days) 336.98K USD
Shares Outstanding 35.76M
Float 24.52M
Short Ratio 7.19
% Held by Insiders 0.26%
% Held by Institutions 105.22%
Shares Short 1.9M
Short % of Float 9.43%
Short % of Shares Outstanding 5.31%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 9.02%
Operating Margin (ttm) -14.21%
Gross Margin 100.00%
EBITDA Margin -13.55%

Management Effectiveness

Return on Assets (ttm) -1.43%
Return on Equity (ttm) 1.80%

Income Statement

Revenue (ttm) 127.7M USD
Revenue Per Share (ttm) 3.59 USD
Quarterly Revenue Growth (yoy) -91.70%
Gross Profit (ttm) 267.63M USD
EBITDA -17311000 USD
Net Income Avi to Common (ttm) 11.52M USD
Diluted EPS (ttm) 0.29
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 602.14M USD
Total Cash Per Share (mrq) 16.84 USD
Total Debt (mrq) 4.63M USD
Total Debt/Equity (mrq) 0.71 USD
Current Ratio (mrq) 23.348
Book Value Per Share (mrq) 18.24

Cash Flow Statement

Operating Cash Flow (ttm) -113746000 USD
Levered Free Cash Flow (ttm) -132718496 USD

Profile of iTeos Therapeutics

Country United States
State MA
City Watertown
Address 321 Arsenal Street
ZIP 02472
Phone 339 217 0161
Website https://www.iteostherapeutics.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 125

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Q&A For iTeos Therapeutics Stock

What is a current ITOS stock price?

iTeos Therapeutics ITOS stock price today per share is 13.53 USD.

How to purchase iTeos Therapeutics stock?

You can buy ITOS shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for iTeos Therapeutics?

The stock symbol or ticker of iTeos Therapeutics is ITOS.

Which industry does the iTeos Therapeutics company belong to?

The iTeos Therapeutics industry is Biotechnology.

How many shares does iTeos Therapeutics have in circulation?

The max supply of iTeos Therapeutics shares is 35.84M.

What is iTeos Therapeutics Price to Earnings Ratio (PE Ratio)?

iTeos Therapeutics PE Ratio is now.

What was iTeos Therapeutics earnings per share over the trailing 12 months (TTM)?

iTeos Therapeutics EPS is -3.15 USD over the trailing 12 months.

Which sector does the iTeos Therapeutics company belong to?

The iTeos Therapeutics sector is Healthcare.

iTeos Therapeutics ITOS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16402.53 USD
+0.02
3.42B USD 16347.38 USD 16420.92 USD 3.42B USD
NASDAQ Global Market Composite NQGM 2287.53 USD
+0.68
2277.12 USD 2296.84 USD
NASDAQ Biotechnology NBI 4441.63 USD
-0.1
4426.59 USD 4461.88 USD
NASDAQ HealthCare IXHC 1014.1 USD
+0.18
1011.36 USD 1017.55 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD